Atossa Therapeutics (ATOS) Short Interest Ratio & Short Volume → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free ATOS Stock Alerts $1.66 +0.14 (+9.21%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Atossa Therapeutics Short Interest DataCurrent Short Volume12,350,000 sharesPrevious Short Volume10,560,000 sharesChange Vs. Previous Month+16.95%Dollar Volume Sold Short$21.12 millionShort Interest Ratio / Days to Cover7.6Last Record DateApril 15, 2024Outstanding Shares125,300,000 sharesPercentage of Shares Shorted9.86%Today's Trading Volume1,360,532 sharesAverage Trading Volume2,258,196 sharesToday's Volume Vs. Average60% Short Selling Atossa Therapeutics ? Sign up to receive the latest short interest report for Atossa Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATOS Short Interest Over TimeATOS Days to Cover Over TimeATOS Percentage of Float Shorted Over Time Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Atossa Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202412,350,000 shares $21.12 million +17.0%N/A7.6 $1.71 3/31/202410,560,000 shares $19.01 million +24.5%N/A7.7 $1.80 3/15/20248,480,000 shares $10.94 million +18.6%N/A9 $1.29 2/29/20247,150,000 shares $6.99 million +1.6%N/A13.6 $0.98 2/15/20247,040,000 shares $7.11 million +2.9%N/A16.8 $1.01 1/31/20246,840,000 shares $5.84 million -2.2%N/A17.4 $0.85 Get the Latest News and Ratings for ATOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atossa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20246,990,000 shares $6.36 million +9.9%N/A18.4 $0.91 12/31/20236,360,000 shares $5.60 million +1.0%N/A16.7 $0.88 12/15/20236,300,000 shares $4.67 million +1.0%N/A19.3 $0.74 11/30/20236,240,000 shares $4.64 million -2.0%N/A19.3 $0.74 11/15/20236,370,000 shares $4.17 million -4.2%N/A17.4 $0.65 10/31/20236,650,000 shares $4.46 million -5.7%N/A16.4 $0.67 10/15/20237,050,000 shares $4.65 million -2.8%N/A16.3 $0.66 9/30/20237,250,000 shares $5.34 million -8.8%N/A13.1 $0.74 9/15/20237,950,000 shares $6.28 million -3.1%N/A9.7 $0.79 8/31/20238,200,000 shares $6.48 million -1.8%N/A9.6 $0.79 8/15/20238,350,000 shares $7.36 million -1.7%N/A8.6 $0.88 7/31/20238,490,000 shares $9.34 million -2.6%N/A9.1 $1.10 7/15/20238,720,000 shares $10.81 million +12.5%N/A9.5 $1.24 6/30/20237,750,000 shares $9.77 million +6.9%N/A9.8 $1.26 6/15/20237,250,000 shares $6.52 million -3.6%N/A14.4 $0.90 5/31/20237,520,000 shares $6.99 million -3.2%N/A16.1 $0.93 5/15/20237,770,000 shares $5.50 million -3.7%N/A22.4 $0.71 4/30/20238,070,000 shares $5.16 million -3.1%N/A24.9 $0.64 4/15/20238,330,000 shares $6.12 million -1.3%N/A24.4 $0.74 3/31/20238,440,000 shares $6.12 million -1.9%N/A19.4 $0.72 3/15/20238,600,000 shares $5.59 million +0.6%N/A17.1 $0.65 2/28/20238,550,000 shares $6.33 million -2.2%N/A15.5 $0.74 2/15/20238,740,000 shares $6.69 million -0.6%N/A15.9 $0.77 1/31/20238,790,000 shares $7.04 million -3.2%N/A15.6 $0.80 1/15/20239,080,000 shares $7.75 million -1.7%N/A15.5 $0.85 12/30/20229,240,000 shares $4.88 million -3.7%N/A18.1 $0.53 12/15/20229,590,000 shares $5.61 million -4.3%N/A21.2 $0.59 11/30/202210,020,000 shares $7.52 million -4.1%N/A22.4 $0.75 11/15/202210,450,000 shares $8.58 million -0.2%N/A23.7 $0.82 10/31/202210,470,000 shares $10.32 million -1.2%N/A19.5 $0.99 10/15/202210,600,000 shares $8.59 million -5.8%N/A19.2 $0.81 9/30/202211,250,000 shares $9.37 million -1.6%N/A18.9 $0.83 9/15/202211,430,000 shares $10.53 million -2.8%N/A11.8 $0.92 8/31/202211,760,000 shares $10.83 million -1.3%N/A10.1 $0.92Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. ATOS Short Interest - Frequently Asked Questions What is Atossa Therapeutics' current short interest? Short interest is the volume of Atossa Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 12,350,000 shares of ATOS short. Learn More on Atossa Therapeutics' current short interest. What is a good short interest ratio for Atossa Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATOS shares currently have a short interest ratio of 8.0. Learn More on Atossa Therapeutics's short interest ratio. Which institutional investors are shorting Atossa Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Atossa Therapeutics: Concourse Financial Group Securities Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Atossa Therapeutics' short interest increasing or decreasing? Atossa Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 12,350,000 shares, an increase of 17.0% from the previous total of 10,560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Atossa Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Atossa Therapeutics: Generation Bio Co. (3.26%), Alimera Sciences, Inc. (0.21%), Rigel Pharmaceuticals, Inc. (2.95%), Lifecore Biomedical, Inc. (6.30%), Incannex Healthcare Inc. (0.36%), Omeros Co. (23.62%), Eliem Therapeutics, Inc. (3.26%), G1 Therapeutics, Inc. (4.63%), Veru Inc. (7.55%), Design Therapeutics, Inc. (7.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Atossa Therapeutics stock? Short selling ATOS is an investing strategy that aims to generate trading profit from Atossa Therapeutics as its price is falling. ATOS shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Atossa Therapeutics? A short squeeze for Atossa Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATOS, which in turn drives the price of the stock up even further. How often is Atossa Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATOS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Generation Bio Short Interest Alimera Sciences Short Interest Rigel Pharmaceuticals Short Interest Lifecore Biomedical Short Interest Incannex Healthcare Short Interest Omeros Short Interest Eliem Therapeutics Short Interest G1 Therapeutics Short Interest Veru Short Interest Design Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATOS) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityAutomatic Income (from home)Awesomely, LLCThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group